MSH|^~\&|LAB|SMH|||202003021202||ORU^R01|4178804|D|2.3|||AL|NE
PID|1||SM00047453|SM47225|IPCTEST^SWITCHPATIENT^B||19880808|F||||||||||SM004256/19|9874689119
OBR|1|40011^LAB|00030173^0203:HC00001R^LAB^020320:HC1^40011|220.8900^INR^INR^^^6301-6||202003021104|202003021103|||||||202003021103||||||||||LAB|F||||
NTE|1||***Edit to Patient Demographics***
NTE|2||Patient gender/age has been not edited. Reference ranges,
NTE|3||H/L flagging and the calculated eGFR on this sample is not
NTE|4||impacted.
OBX|1|ST|220.9000^INR R^INR^^6301-6^6301-6|1|2.0^^Y||0.8-1.2|H||A^S|F|||202003021104
NTE|1||INR Therapeutic Ranges:
NTE|2||    Mechanical Heart Valves 2.5 - 3.5
NTE|3||    Other indications       2.0 - 3.0

MSH|^~\&|LAB|SMH|||202003021202||ORU^R01|4178805|D|2.3|||AL|NE
PID|1||SM00047453|SM47225|IPCTEST^SWITCHPATIENT^B||19880808|F||||||||||SM004256/19|9874689119
OBR|1|40013^LAB|00030174^0203:C00006R^LAB^020320:C6^40013|500.1000^CP7^Chem 7 - Glu R,Urea,Crea,Lytes^^^XXX-1710||202003021114|202003021113|||||||202003021113||||||||||LAB|F||||
NTE|1||***Edit to Patient Demographics***
NTE|2||Patient gender/age has been not edited. Reference ranges,
NTE|3||H/L flagging and the calculated eGFR on this sample is not
NTE|4||impacted.
NTE|5||SWITCH FOR LUMED
OBX|1|ST|500.1900^NA^Sodium^^2951-2^2951-2|1|150^^Y|mmol/L|135-145|H||A^S|F|||202003021114
OBX|2|ST|500.2000^K^Potassium^^2823-3^2823-3|1|4.0^^Y|mmol/L|3.5-5.0|N||A^S|F|||202003021114
OBX|3|ST|500.2100^CL^Chloride^^2075-0^2075-0|1|100^^Y|mmol/L|98-108|N||A^S|F|||202003021114
OBX|4|ST|500.2200^BICARB^Bicarbonate^^1962-0^1962-0|1|25^^Y|mmol/L|20-30|N||A^S|F|||202003021114
OBX|5|ST|500.2300^GAP^Anion Gap^^33037-3^33037-3|1|25^^Y|mmol/L|3-16|H||A^S|F|||202003021114
OBX|6|ST|500.2400^UREA^Urea^^14937-7^22664-7|1|5^^Y|mmol/L|2-9|N||A^S|F|||202003021114
OBX|7|ST|500.2600^CR^Creatinine Modified Jaffe^^14682-9^14682-9|1|60^^Y|umol/L|45-90|N||A^S|F|||202003021114
OBX|8|ST|500.2700^EGFR^Glomerular Filtration Rate Est^^33914-3^33914-3|1|117^^Y|mL/min|>60|N||A^S|F|||202003021114
OBX|9|ST|500.2900^GLU^Glucose, Random^^14749-6^14749-6|1|5.0^^Y|mmol/L|3.6-7.8|N||A^S|F|||202003021114

MSH|^~\&|MIC|SMH|||202003021202||ORU^R01|4178806|D|2.3|||AL|NE
PID|1||SM00047453|SM47225|IPCTEST^SWITCHPATIENT^B||19880808|F||||||||||SM004256/19|9874689119
OBR|1|40012^MIC|00030173^20:U0000028R^MIC^20:U28^40012|500.1000^U^Urine Culture^^^630-4||202003021104|202003021103|||||||202003021103|Urine^^^Midstream urine|||||||||MB|F||||
NTE|1||***Edit to Patient Demographics***
NTE|2||Patient gender/age has been not edited. Reference ranges,
NTE|3||H/L flagging and the calculated eGFR on this sample is not
NTE|4||impacted.
OBX|1|ST|500.1000^U^Urine Culture^^^630-4^S:CI1GX|1|Contaminants >100 x 10*6 CFU/L||||||F|||202003021104

MSH|^~\&|MIC|SMH|||202003021202||ORU^R01|4178807|D|2.3|||AL|NE
PID|1||SM00047453|SM47225|IPCTEST^SWITCHPATIENT^B||19880808|F||||||||||SM004256/19|9874689119
OBR|1|40014^MIC|00030175^20:U0000029R^MIC^20:U29^40014|500.1000^U^Urine Culture^^^630-4||202003021134|202003021134|||||||202003021134|Urine^^^Midstream urine|||||||||MB|F||||
NTE|1||***Edit to Patient Demographics***
NTE|2||Patient gender/age has been not edited. Reference ranges,
NTE|3||H/L flagging and the calculated eGFR on this sample is not
NTE|4||impacted.
OBX|1|ST|500.1000^U^Urine Culture^^^630-4^S:NG|1|No growth||||||F|||202003021136